A detailed history of Utah Retirement Systems transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Utah Retirement Systems holds 16,483 shares of NBIX stock, worth $2.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,483
Previous 16,483 -0.0%
Holding current value
$2.07 Million
Previous $2.27 Million 16.39%
% of portfolio
0.02%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$130.86 - $143.19 $26,172 - $28,638
-200 Reduced 1.2%
16,483 $2.27 Million
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $9,402 - $11,710
100 Added 0.6%
16,683 $1.88 Million
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $17,906 - $20,974
-200 Reduced 1.19%
16,583 $1.56 Million
Q4 2022

Feb 15, 2023

SELL
$106.72 - $127.06 $21,344 - $25,412
-200 Reduced 1.18%
16,783 $2 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $27,609 - $32,343
300 Added 1.8%
16,983 $1.8 Million
Q1 2022

May 13, 2022

SELL
$72.45 - $94.81 $21,735 - $28,443
-300 Reduced 1.77%
16,683 $1.56 Million
Q3 2021

Nov 16, 2021

SELL
$86.18 - $99.03 $68,944 - $79,224
-800 Reduced 4.5%
16,983 $1.63 Million
Q2 2021

Aug 16, 2021

BUY
$89.43 - $102.27 $8,943 - $10,227
100 Added 0.57%
17,783 $1.73 Million
Q1 2021

May 17, 2021

SELL
$87.57 - $119.4 $70,056 - $95,520
-800 Reduced 4.33%
17,683 $1.72 Million
Q4 2020

Feb 16, 2021

BUY
$86.91 - $108.33 $69,528 - $86,664
800 Added 4.52%
18,483 $1.77 Million
Q3 2020

Nov 16, 2020

BUY
$96.16 - $135.15 $19,232 - $27,030
200 Added 1.14%
17,683 $1.7 Million
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $25,527 - $39,108
300 Added 1.75%
17,483 $2.13 Million
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $8,382 - $10,150
100 Added 0.59%
17,183 $1.55 Million
Q2 2019

Aug 14, 2019

BUY
$72.24 - $91.27 $7,368 - $9,309
102 Added 0.6%
17,083 $1.44 Million
Q1 2019

May 15, 2019

BUY
$69.31 - $91.53 $26,407 - $34,872
381 Added 2.3%
16,981 $1.5 Million
Q4 2018

Feb 08, 2019

BUY
$68.32 - $124.36 $6,831 - $12,436
100 Added 0.61%
16,600 $1.19 Million
Q1 2018

May 15, 2018

BUY
$75.88 - $92.43 $15,176 - $18,486
200 Added 1.23%
16,500 $1.37 Million
Q4 2017

Feb 14, 2018

BUY
$58.53 - $77.59 $17,559 - $23,277
300 Added 1.88%
16,300 $1.27 Million
Q3 2017

Nov 13, 2017

BUY
$47.97 - $61.28 $767,520 - $980,480
16,000
16,000 $980,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.